Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 3 Carcinoma, Non-Small-Cell Lung 3 Nasopharyngeal Carcinoma 2 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Recurrence 1 Melanoma 1 Lymphoma 1 Lung Neoplasms 1 Hodgkin Disease 1 Breast Neoplasms 1 Advanced or Metastatic Non-squamous Non-small-cell Lung Cancer 1 Advanced Malignant Tumors 1

Interventions

Cyclophosphamide 77 Docetaxel 69 Capecitabine 64 Trastuzumab 61 Paclitaxel 50 Tamoxifen 47 Epirubicin 47 Letrozole 44 pyrotinib 40 Fulvestrant 37 Doxorubicin 35 Vinorelbine 33 Radiotherapy 32 Carboplatin 32 Anastrozole 28 exemestane 27 Neoadjuvant Therapy 24 Drug Therapy 22 Fluorouracil 21 palbociclib 20 Exercise 20 Chemotherapy, Adjuvant 19 Bevacizumab 18 pertuzumab 16 Goserelin 16 Cisplatin 16 liposomal doxorubicin 15 Mammography 14 Gemcitabine 14 Blood Specimen Collection 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Breast Neoplasms × SHR-1701 × Clear all

NCT04355858 2022-07-26

MULAN

Fudan University

Phase 2 Unknown

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡